Month: May 2023

Figure 1. General Thorn Project Location Map and Copper Geochemistry.Figure 2. Drilling the first hole of 2023 at the Camp Creek Copper Target, hole THN23-258.Figure 3. Water Sampling at Camp Creek and Core Logging.VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) is pleased to announce the commencement of drilling for the 2023 exploration program at its flagship Thorn Project located along the northwestern extent of the Golden Triangle trend in British Columbia. The program is fully funded and was planned through the joint technical committee between the Company and our 19.9% strategic investor, BHP. The 2023 program will focus on drilling the Camp Creek Copper Porphyry Target and the Trapper Gold Target. The two targets...

BURLINGTON, Mass. and JERUSALEM, May 17, 2023 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported first quarter 2023 financial results and provided an operational update. Recent Financial and Operational HighlightsFor the three months ended March 31, 2023, revenues were $6.6 million, a 10% increase as compared to the fourth quarter of 2022. The Company shipped a net total of 48 Deep TMS™ new systems during the first quarter of 2023, bringing BrainsWay’s total Deep TMS installed base to 932 total systems as of March 31, 2023, an 18% increase from the installed base at the same point in the prior year. As of March 31, 2023, the Company had shipped 453 obsessive-compulsive disorder (OCD) coils...

User Fee Goal Date: October 17, 2023 WALTHAM, Mass., May 17, 2023 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has accepted its resubmission of a New Drug Application (NDA) for XPHOZAH® (tenapanor) for the control of serum phosphate in adult patients with chronic kidney disease on dialysis who have had an inadequate response or intolerance to a phosphate binder therapy. The FDA has determined that the NDA is a class 2 review, which results in a six-month review period from the date of resubmission. The FDA has set a user fee goal date of October 17, 2023. The company expects XPHOZAH to be commercially...

BETHESDA, Md., May 17, 2023 (GLOBE NEWSWIRE) — Liquidity Services (Nasdaq: LQDT), a leading global commerce company powering the circular economy, today announced Jorge Celaya, Executive Vice President and Chief Financial Officer will participate in the upcoming Barrington Research Virtual Spring Investment Conference on Thursday, May 18, 2023. This virtual conference will bring together investors and management teams from approximately 40 publicly-traded companies operating in diverse sectors such as Business Services, Industrial, Broadcasting, and Financial Services. During the conference, Mr. Celaya will engage in virtual one-on-one meetings with investors, discussing how Liquidity Services pioneers sustainable e-commerce marketplace solutions that power the circular economy to create a better future for organizations, individuals,...

REYKJAVIK, Iceland, May 17, 2023 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Morgan Stanley Annual Sustainable Finance Summit on May 22, 2023. Alvotech is scheduled to hold a fireside chat on May 22, 2023 at 10:15 am ET and will host investor meetings at the conference. Alvotech is committed to the promise of biosimilars, which expand patient access to medicines globally and contribute to the overall sustainability of healthcare systems by providing lower cost alternatives to high-priced biologic medicines. Part of Alvotech’s commitment is understanding and mitigating any impact on the natural environment. All of the electrical power for Alvotech’s R&D and manufacturing...